While semaglutide can be a powerful tool for weight management and managing type 2 diabetes in women, it's important to be cognizant of potential side effects. Common side effects may include nausea, vomiting, diarrhea, and constipation. These symptoms are usually mild and tend to subside over ti

Viking Therapeutics has formed a mutually beneficial alliance with U.S. biopharmaceutical companies to develop and manufacture its GLP-1 drug candidate, VK2735. This marks a significant advancement in securing dependable production capabilities for these vital therapeutic agents. The agreement en